News - Page 232 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Post published:December 22, 2020
Post category:Press Release

Read more about the article MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

Post published:December 22, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Post published:December 22, 2020
Post category:Press Release

Read more about the article MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:December 21, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Post published:December 21, 2020
Post category:Press Release

Read more about the article PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

Post published:December 21, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program

Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program

Post published:December 21, 2020
Post category:Press Release

Read more about the article BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC

BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC

Post published:December 21, 2020
Post category:Press Release

Read more about the article Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases

Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases

Post published:December 19, 2020
Post category:News

Read more about the article Entheon Biomedical Announces Private Placement

Entheon Biomedical Announces Private Placement

Post published:December 18, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.